# Adenomyosis and ART

> **NCT05937490** · PHASE4 · UNKNOWN · sponsor: **Azienda Ospedaliero-Universitaria di Modena** · enrollment: 500 (estimated)

## Conditions studied

- Adenomyosis

## Interventions

- **DRUG:** Enantone
- **DRUG:** Dienogest 2 MG (milligram)
- **DRUG:** Enantone
- **DRUG:** long GnRH agonist or flexible GnRH antagonist protocol.

## Key facts

- **NCT ID:** NCT05937490
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Modena
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-27
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937490, "Adenomyosis and ART". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05937490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*